sanofi (SAN:EN Paris)
Transactions by SANOFI (SAN) in the last 6 months
Sanofi (ENXTPA:SAN) commences share repurchases on June 30, 2015, under the program mandated by the shareholders in the Annual General Meeting held on May 4, 2015. As per the mandate, the company is authorized to repurchase up to 10% of the share capital such that it does not at any time hold a number of shares representing more than 10% of its issued capital. The shares will be repurchased at a maximum purchase price of €120 per share for €15,832.41 million. The number ...
Sanofi (ENXTPA:SAN) made an offer to acquire Rare Pediatric Disease Priority Review Voucher from Retrophin, Inc. (NasdaqGM:RTRX) on May 7, 2015. Sanofi (ENXTPA:SAN) signed an agreement to acquire Rare Pediatric Disease Priority Review Voucher from Retrophin, Inc. (NasdaqGM:RTRX) for approximately $250 million in cash on May 22, 2015. Under the terms of agreement, Retrophin will receive a payment of $150 million, followed by two equal installments of $47.5 million in ...
MyoKardia, Inc. announced that it will receive $46,000,001 in a round of funding on April 20, 2015. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Cormorant Asset Management, LLC
Cowen Group, Inc.
|AbbVie Inc||$63.98 USD||-0.53|
|Amgen Inc||$155.89 USD||+0.17|
|Bayer AG||€121.01 EUR||-0.197|
|Medtronic PLC||$73.56 USD||+0.04|
|Novo Nordisk A/S||kr369.50 DKK||-0.60|
|View Industry Companies|